Abstract: Disclosed is an acidic oil-in-water type emulsified condiment comprising 1 to 40% by mass of an edible oil, 30 to 60% by mass of water, a thickener, a yolk, a volatile acid, and a nonvolatile acid, wherein the mass ratio between the content of the volatile acid and the content of the nonvolatile acid is 1:50 to 20:1, and the acidic oil-in-water type emulsified condiment has a dissolved oxygen concentration of 0.1 to 10% O2, a pH of 3.0 to 4.0, a water activity of 0.90 to 0.96, and a viscosity (20° C.) of 50 Pa·s or higher.

Abstract: A method of producing a carboxymethyl-group-containing modified hyaluronic acid and/or a salt thereof includes a step of subjecting, in a water-containing solvent having a temperature of 30° C. or less, a dissolved raw material hyaluronic acid and/or a salt thereof to a reaction with a haloacetic acid and/or a salt thereof, the water-containing solvent including water or a liquid mixture of a water-soluble organic solvent and water, a ratio of the water-soluble organic solvent in the liquid mixture being 60 v/v % or less.

Abstract: [Object] The present invention provides an oil composition in which oxidation of oil is inhibited and a method of inhibiting oxidation of oil. [Solving Means] Provided is an oil composition containing oil, an ionic surfactant, and a polyhydric alcohol, in which a value L2-L1 calculated by the following method is positive.

Abstract: A method for manufacturing a hyaluronic acid derivative includes a step of reacting a carboxymethyl group-containing modified hyaluronic acid and/or a salt thereof with an organic compound containing an amino group and having a molecular weight of equal to or greater than 90.

Abstract: A method for producing a composition containing a DHA-containing glyceride, including a step of obtaining a composition containing a DHA-containing glyceride, in which an esterification reaction is conducted by reacting a lipase with a raw material oil and fat containing highly unsaturated fatty acid as a constituent fatty acid in the presence of water and a lower alcohol to give a composition containing a DHA-containing glyceride, wherein a reaction liquid in the reaction has a water content of 0.4% by mass or more, and wherein the composition containing a DHA-containing glyceride has an acid value of 12 or less.

Abstract: Provided is a norovirus deactivator, including a lysozyme component that includes at least one kind selected from lysozyme and/or a salt thereof, and a denatured product thereof.

Abstract: An injection bag is formed of a multilayer film, and includes an intermediate layer that includes a mixture of 60 to 90 mass % of a crystalline polyamide resin and 10 to 40 mass % of a noncrystalline polyamide resin. The crystalline polyamide resin has a combined content of a monomer and a low-molecular-weight polymer of 0.8 mass % or less. The noncrystalline polyamide resin includes a semi-aromatic polyamide.

Abstract: Disclosed is an acidic oil-in-water type emulsified condiment comprising one or more chelating agents selected from citric acid, malic acid, phosphoric acid, lactic acid, succinic acid, fumaric acid, gluconic acid, and EDTA, acetic acid, a sugar, a yolk, an edible oil, a thickener, and water, wherein the content of the edible oil is 1 to 40% by mass, and the acidic oil-in-water type emulsified condiment has a water activity of 0.90 to 0.96, a pH of 3.0 to 4.0, a viscosity (20° C.) of 50 to 600 Pa·s, and a b* value of 10 to 20 in an L*a*b* color system when preserved at 40° C. for 4 months.

Abstract: Disclosed is an acidic oil-in-water type emulsified condiment comprising 1 to 40% by mass of an edible oil, 30 to 60% by mass of water, a thickener, a yolk, a volatile acid, and a nonvolatile acid, wherein the mass ratio between the content of the volatile acid and the content of the nonvolatile acid is 1:50 to 20:1, and the acidic oil-in-water type emulsified condiment has a dissolved oxygen concentration of 0.1 to 10% O2, a pH of 3.0 to 4.0, a water activity of 0.90 to 0.96, and a viscosity (20° C.) of 50 Pa·s or higher.

Abstract: Provided is a hyaluronic acid and/or a salt thereof having an average molecular weight of 3,500 or less, a proportion of disaccharide of 1 mass % or more and 30 mass % or less, a content of chlorine of 1 mass % or less, a content of sulfur of 1 mass % or less, and a bulk density of more than 0.25 g/cm3.

Abstract: The present invention provides a sesame-containing acidic emulsified liquid seasoning capable of sufficiently giving a roasted sesame flavor even after storage. The sesame-containing acidic emulsified liquid seasoning according to the present invention comprises ground roasted sesame, gum substance, egg yolk and edible oil and has a viscosity of 0.1 to 5 Pa·s and a total light transmittance, which is determined by measuring the turbidity of the sesame-containing acidic emulsified liquid seasoning using integrating sphere-type electrophotometry, of 1.5 to 10%.

Abstract: [Problem] To suppress the onset of adverse effects of drugs that cause gastric ulcers as an adverse effect. [Solution] The onset of gastric ulcers induced by a drug is suppressed by incorporating, into a pharmaceutical composition containing a drug having gastric ulcers as an adverse effect, a high-molecular polysaccharide that has a molecular weight of 800,000-3,000,000 and that produces a gel when a 0.3% aqueous solution thereof is added dropwise to artificial gastric juice.

Abstract: A method of producing a carboxymethyl-group-containing modified hyaluronic acid and/or a salt thereof includes a step of subjecting, in a water-containing solvent having a temperature of 30° C. or less, a dissolved raw material hyaluronic acid and/or a salt thereof to a reaction with a haloacetic acid and/or a salt thereof, the water-containing solvent including water or a liquid mixture of a water-soluble organic solvent and water, a ratio of the water-soluble organic solvent in the liquid mixture being 60 v/v % or less.

Abstract: Provided is a method of producing a lower alcohol ester of fatty acid-containing composition, the method including treating a raw material oil and fat containing an EPA-containing glyceride with a lipase to obtain a lower alcohol ester of fatty acid-containing composition including a lower alcohol ester of EPA, a content of water in a reaction solution in the treating being 0.4 mass % or more.

Abstract: Provided is a pull-top style discharge member for a package to be mounted on a dispenser. The package discharge member is provided with an outer frame 70 having an opening in the center thereof, a cap 71 that closes the opening in the outer frame 70, and can open the opening by being pulled, and a sheet 61 disposed on the reverse surface of the outer frame 70 and the cap 71 and formed with a discharge hole 61a in the form of slits to allow passage of food contents. The sheet 61 and the outer frame 70 are welded together, and metallocene polyethylene is used as the material of the outer frame 70, while polypropylene is used as the material of the sheet 61.

Abstract: A modified hyaluronic acid and/or a salt thereof comprises a glycerin skeleton-containing group shown by the following general formula (1), —O—CH2—CHOH—CH2—OR1??(1) wherein, R1 represents a linear or branched alkyl group, or a linear or branched alkenyl group.

Abstract: An oral preparation for promoting expression of TGF-? includes as an active ingredient hyaluronic acid or a pharmaceutically acceptable salt thereof, the oral preparation promoting expression of TGF-? in plasma. In addition, an oral preparation for suppressing production of a pain-producing substance includes as an active ingredient hyaluronic acid or a pharmaceutically acceptable salt thereof, the oral preparation suppressing production of a pain-producing substance by promoting expression of TGF-? in plasma. In addition, an oral preparation for suppressing production of a pain-producing substance includes as an active ingredient hyaluronic acid or a pharmaceutically acceptable salt thereof, the oral preparation suppressing production of a pain-producing substance PGE2 and/or bradykinin.

Abstract: Provided a method of producing a purified hyaluronic acid type which comprises adding a water-soluble organic medium to a solution which comprises a hyaluronic acid type having an average molecular weight of 400 to 100,000 and has a pH of 3 or less to obtain a suspension, and adjusting a pH of the suspension in a range of 3.5 to 8 to precipitate a purified hyaluronic acid type.

Abstract: Provided is a pull-top style discharge member for a package to be mounted on a dispenser. The package discharge member is provided with an outer frame 70 having an opening in the center thereof, a cap 71 that closes the opening in the outer frame 70, and can open the opening by being pulled, and a sheet 61 disposed on the reverse surface of the outer frame 70 and the cap 71 and formed with a discharge hole 61a in the form of slits to allow passage of food contents. The sheet 61 and the outer frame 70 are welded together, and metallocene polyethylene is used as the material of the outer frame 70, while polypropylene is used as the material of the sheet 61.

Abstract: An egg white hydrolysate having a reduced sulfur smell characteristic to egg white and a production method therefor are provided. An egg white hydrolysate having a low hydrogen sulfide content and a reduced sulfur smell can be obtained through a pretreatment step of denaturing egg white by thermally treating a diluted egg white solution under conditions of a pH of 9 to 12 and a temperature of 55° C. to 90° C., the diluted egg white solution having been prepared by diluting 1 part of liquid egg white with 0.4 to 3 parts of water, and a step of performing hydrolysis with a protease.